株式会社Veritas In Silico Logo

株式会社Veritas In Silico

An in silico drug discovery platform creating mRNA-targeting medicines with pharma partners.

130A | T

Overview

Corporate Details

ISIN(s):
JP3155340007
LEI:
Country:
Japan
Address:
品川区西五反田一丁目11番1号
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Veritas In Silico Inc. is a drug discovery platform company specializing in the creation of small molecule and nucleic acid medicines that target messenger RNA (mRNA). The company utilizes its proprietary *in silico* (computational simulation) technologies, combining quantum chemistry calculations with robust high-throughput screening, to design novel therapeutics for previously undruggable targets. Its core business involves establishing joint research and development partnerships with major pharmaceutical companies, earning revenue through milestone payments and future royalties. Veritas In Silico has secured numerous collaborations with leading firms such as Takeda, Shionogi, and Mitsubishi Gas Chemical. The company was listed on the Tokyo Stock Exchange Growth Market in February 2024.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 08:00
Interim Report
半期報告書-第10期(2025/01/01-2025/12/31)
Japanese 177.7 KB
2025-08-14 08:00
Interim Report
確認書
Japanese 8.8 KB
2025-03-28 05:18
Post-Annual General Meeting Information
臨時報告書
Japanese 27.1 KB
2025-03-28 02:47
Regulatory News Service
内部統制報告書-第9期(2024/01/01-2024/12/31)
Japanese 22.5 KB
2025-03-28 02:47
Regulatory News Service
確認書
Japanese 8.8 KB
2025-03-28 02:46
Annual Report
有価証券報告書-第9期(2024/01/01-2024/12/31)
Japanese 3.1 MB
2024-08-14 08:00
Interim Report
確認書
Japanese 8.7 KB
2024-08-14 08:00
Interim Report
半期報告書-第9期(2024/01/01-2024/12/31)
Japanese 171.1 KB
2024-05-15 09:55
Report Publication Announcement
確認書
Japanese 8.7 KB
2024-05-15 08:00
Quarterly Report
四半期報告書-第9期第1四半期(2024/01/01-2024/03/31)
Japanese 146.8 KB
2024-03-15 07:01
Post-Annual General Meeting Information
臨時報告書
Japanese 23.2 KB
2024-03-15 07:00
Annual Report
有価証券報告書-第8期(2023/01/01-2023/12/31)
Japanese 3.1 MB
2024-02-08 01:05
Major Shareholding Notification
臨時報告書
Japanese 21.1 KB
2024-01-31 07:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.4 MB
2024-01-23 07:00
Registration Form
訂正有価証券届出書(新規公開時)
Japanese 2.4 MB

Automate Your Workflow. Get a real-time feed of all 株式会社Veritas In Silico filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for 株式会社Veritas In Silico

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for 株式会社Veritas In Silico via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Incannex Healthcare Inc. Logo
Develops oral cannabinoid/psychedelic therapies for sleep apnea, arthritis & anxiety.
United States of America
IXHL
Incross Co.,Ltd. Logo
A digital marketing firm offering data-driven ad solutions via proprietary AI and video platforms.
South Korea
216050
INEST,Inc. Logo
Offers ASP solutions and HR support to businesses and sells mobile devices to consumers.
Japan
7111
Innate Pharma Logo
Clinical-stage biotech developing NK cell-engaging antibodies for cancer immunotherapy.
France
IPH
Innovation Inc. Logo
Drives B2B growth via digital media, IT solutions, M&A advisory, and venture capital.
Japan
3970
Innventure, Inc. Logo
Founds, funds, and scales companies using breakthrough R&D from multinational corporations.
United States of America
INV
Inotiv, Inc. Logo
CRO providing nonclinical drug discovery, research models, and analytical services for life sciences.
United States of America
NOTV
INTAGE HOLDINGS Inc. Logo
Marketing research & business intelligence for consumer goods, healthcare & enterprise tech.
Japan
4326
IntegraGen Logo
Genomic analysis & molecular diagnostics for cancer and rare diseases for researchers and labs.
France
ALINT
INTENSITY THERAPEUTICS, INC. Logo
Develops injected therapies to kill tumors locally and activate a systemic immune response.
United States of America
INTS

Talk to a Data Expert

Have a question? We'll get back to you promptly.